EISSN: 2980-0749
  Ana Sayfa | Amaç ve Kapsam | Dergi Hakkında | İçindekiler | Arşiv | Yayın Arama | Yazarlara Bilgi | Etik İlkeler | İletişim  
2023, Cilt 21, Sayı 1, Sayfa(lar) 034-046
[ Özet ] [ PDF ] [ Benzer Makaleler ] [ Yazara E-Posta ] [ Editöre E-Posta ]
Agreement Between MDRD and CKD-EPI eGFR Results: A Large Population-Based Method Comparison
Gülsüm Feyza Türkeş1, Serkan Yıldız2, Özlem Gürsoy Doruk1, Pembe Keskinoğlu3, Tuncay Küme1, Ali Rıza Şişman1
1Dokuz Eylül Üniversitesi, Tıbbi Biyokimya Anabilim Dalı, İzmir, Türkiye
2Dokuz Eylül Üniversitesi, İç Hastalıkları Anabilim Dalı Nefroloji Bilim Dalı, İzmir, Türkiye
3Dokuz Eylül Üniversitesi, Biyoistatistik ve Tıbbi Bilişim Anabilim Dalı, İzmir, Türkiye
Keywords: eGFR, CKD-EPI, MDRD, Method Comparison
DOI: 10.56615/tkbd.2023.05
Abstract
Aim: Since glomerular filtration rate (GFR) determined by 24 hours urine is cumbersome, nephrologists recommend using an estimated GFR (eGFR). This study aimed to investigate the agreement between Modification of Diet in Renal Disease (MDRD) and Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) eGFR in high case numbers.

Materials and Methods: 56228 eGFR results were included in the study. For agreement between MDRD and CKD-EPI eGFR results, kappa analysis was used. Additionally, the two methods were compared according to the Clinical and Laboratory Standards Institute (CLSI) guidelines.

Results: The category agreement between the two eGFR methods was 84.4%, while the discordance was 15.6%. Incompatibility was found as 3.0%, 33.2%, 13.0%, 7.2% and 1.1% from (GFR category) G1 to G5, respectively. CKD-EPI eGFR results were average 4.4% higher than MDRD. When Chronic Kidney Disease (CKD) stage transition limits were taken as the medical decision limit, the highest difference% was determined to be 9.8% at stage 1-2 transition.

Conclusion: Although the difference between the two methods is <9.8%, the 15.6% categorical discordance will create a follow-up problem in patient monitoring; it also shows that it is not appropriate to use it in a healthy population, given that MDRD produces higher results in low serum creatinine.

  • Top
  • Abstract
  • [ Başa Dön ] [ Özet ] [ PDF ] [ Benzer Makaleler ] [ Yazara E-Posta ] [ Editöre E-Posta ]
    Ana Sayfa | Amaç ve Kapsam | Dergi Hakkında | İçindekiler | Arşiv | Yayın Arama | Yazarlara Bilgi | Etik İlkeler | İletişim